{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:42:45Z","timestamp":1782160965323,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00213-014-3451-3","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T12:57:01Z","timestamp":1392209821000},"page":"2705-2716","source":"Crossref","is-referenced-by-count":23,"title":["Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats"],"prefix":"10.1007","volume":"231","author":[{"given":"Todd M.","family":"Hillhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"3451_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/FBP.0b013e32834aff54","volume":"22","author":"AA Altarifi","year":"2011","unstructured":"Altarifi AA, Negus SS (2011) Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol 22:663\u2013673. doi: 10.1097\/FBP.0b013e32834aff54","journal-title":"Behav Pharmacol"},{"key":"3451_CR2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/FBP.0b013e328358593c","volume":"23","author":"AA Altarifi","year":"2012","unstructured":"Altarifi AA, Miller LL, Negus SS (2012) Role of \u03bc-opioid receptor reserve and \u03bc-agonist efficacy as determinants of the effects of \u03bc-agonists on intracranial self-stimulation in rats. Behav Pharmacol 23:678\u2013692","journal-title":"Behav Pharmacol"},{"key":"3451_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FBP.0b013e328364c0bd","volume":"24","author":"AA Altarifi","year":"2013","unstructured":"Altarifi AA, Rice KC, Negus SS (2013) Abuse-related effects of \u03bc-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure. Behav Pharmacol 24:459\u2013470. doi: 10.1097\/FBP.0b013e328364c0bd","journal-title":"Behav Pharmacol"},{"key":"3451_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1124\/jpet.108.143370","volume":"327","author":"PA Ardayfio","year":"2008","unstructured":"Ardayfio PA, Benvenga MJ, Chaney SF, Love PL, Catlow J, Swanson SP, Marek GJ (2008) The 5-hydroxytryptamine2a receptor antagonist R-(+)-\u03b1-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat. J Pharmacol Exp Ther 327:891\u2013897","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/FBP.0b013e328363d1a4","volume":"24","author":"CT Bauer","year":"2013","unstructured":"Bauer CT, Banks ML, Blough BE, Negus SS (2013a) Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment. Behav Pharmacol 24:448\u2013458. doi: 10.1097\/FBP.0b013e328363d1a4","journal-title":"Behav Pharmacol"},{"key":"3451_CR6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","volume":"168","author":"CT Bauer","year":"2013","unstructured":"Bauer CT, Banks ML, Blough BE, Negus SS (2013b) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850\u2013862. doi: 10.1111\/j.1476-5381.2012.02214.x","journal-title":"Br J Pharmacol"},{"key":"3451_CR7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-3565(25)20214-2","volume":"252","author":"PM Beardsley","year":"1990","unstructured":"Beardsley PM, Hayes BA, Balster RL (1990) The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J Pharmacol Exp Ther 252:953\u2013959","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"3451_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0924-977X(99)00008-5","volume":"9","author":"A Bespalov","year":"1999","unstructured":"Bespalov A, Lebedev A, Panchenko G, Zvartau E (1999) Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur Neuropsychopharmacol 9:377\u2013383","journal-title":"Eur Neuropsychopharmacol"},{"key":"3451_CR10","author":"JS Bonano","year":"2013","unstructured":"Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2013) Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology. doi: 10.1007\/s00213-013-3223-5","journal-title":"Psychopharmacology"},{"key":"3451_CR11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1901\/jeab.1984.42-511","volume":"42","author":"MN Branch","year":"1984","unstructured":"Branch MN (1984) Rate dependency, behavioral mechanisms, and behavioral pharmacology. J Exp Anal Behav 42:511\u2013522","journal-title":"J Exp Anal Behav"},{"key":"3451_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0028-3908(95)00017-Z","volume":"34","author":"I Bresink","year":"1995","unstructured":"Bresink I, Danysz W, Parsons CG, Mutschler E (1995) Different binding affinities of NMDA receptor channel blockers in various brain regions\u2014indication of NMDA receptor heterogeneity. Neuropharmacology 34:533\u2013540","journal-title":"Neuropharmacology"},{"key":"3451_CR13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00213-004-1891-x","volume":"176","author":"J Broadbear","year":"2004","unstructured":"Broadbear J, Winger G, Woods J (2004) Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary\u2014adrenal axis in rhesus monkeys. Psychopharmacology (Berl) 176:398\u2013406","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(25)32909-5","volume":"220","author":"LD Byrd","year":"1982","unstructured":"Byrd LD (1982) Comparison of the behavioral effects of phencyclidine, ketamine, d-amphetamine and morphine in the squirrel monkey. J Pharmacol Exp Ther 220:139\u2013144","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR15","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/nprot.2007.441","volume":"2","author":"WA Carlezon Jr","year":"2007","unstructured":"Carlezon WA Jr, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987\u20132995","journal-title":"Nat Protoc"},{"key":"3451_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(93)90177-O","volume":"620","author":"WA Carlezon Jr","year":"1993","unstructured":"Carlezon WA Jr, Wise RA (1993) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620:339\u2013342","journal-title":"Brain Res"},{"key":"3451_CR17","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1523\/JNEUROSCI.16-09-03112.1996","volume":"16","author":"WA Carlezon","year":"1996","unstructured":"Carlezon WA, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112\u20133122","journal-title":"J Neurosci"},{"key":"3451_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-4328(89)80105-6","volume":"34","author":"D Corbett","year":"1989","unstructured":"Corbett D (1989) Possible abuse potential of the NMDA antagonist MK-801. Behav Brain Res 34:239\u2013246","journal-title":"Behav Brain Res"},{"key":"3451_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbr.2012.05.038","volume":"233","author":"JBI Pe\u00f1a de la","year":"2012","unstructured":"de la Pe\u00f1a JBI, Lee HC, de la Pe\u00f1a IC, Woo TS, Yoon SY, Lee HL et al (2012) Rewarding and reinforcing effects of the NMDA receptor antagonist\u2014benzodiazepine combination, Zoletil\u00ae: difference between acute and repeated exposure. Behav Brain Res 233:434\u2013442. doi: 10.1016\/j.bbr.2012.05.038","journal-title":"Behav Brain Res"},{"key":"3451_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-010-2062-x","volume":"214","author":"M Luca De","year":"2011","unstructured":"De Luca M, Badiani A (2011) Ketamine self-administration in the rat: evidence for a critical role of setting. Psychopharmacology (Berl) 214:549\u2013556","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00008877-200305000-00007","volume":"14","author":"J Vry De","year":"2003","unstructured":"De Vry J, Jentzsch KR (2003) Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine. Behav Pharmacol 14:229\u2013235","journal-title":"Behav Pharmacol"},{"key":"3451_CR22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793\u2013802","journal-title":"Arch Gen Psychiatry"},{"key":"3451_CR23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2009.03.038","volume":"161","author":"E Engin","year":"2009","unstructured":"Engin E, Treit D, Dickson CT (2009) Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 161:359\u2013369","journal-title":"Neuroscience"},{"key":"3451_CR24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0892-0362(94)90023-X","volume":"16","author":"ED French","year":"1994","unstructured":"French ED (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol 16:355\u2013362","journal-title":"Neurotoxicol Teratol"},{"key":"3451_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-009-1530-7","volume":"205","author":"G Gilmour","year":"2009","unstructured":"Gilmour G, Pioli E, Dix S, Smith J, Conway M, Jones W, Loomis S, Mason R, Shahabi S, Tricklebank M (2009) Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for \u201cNMDA antagonist modelling\u201d of schizophrenia. Psychopharmacology (Berl) 205:203\u2013216","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0028-3908(96)00147-5","volume":"35","author":"KA Grant","year":"1996","unstructured":"Grant KA, Colombo G, Grant J, Rogawski MA (1996) Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. Neuropharmacology 35:1709\u20131719","journal-title":"Neuropharmacology"},{"key":"3451_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00634458","volume":"99","author":"LJ Herberg","year":"1989","unstructured":"Herberg LJ, Rose IC (1989) The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology (Berl) 99:87\u201390","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FBP.0000000000000014","volume":"25","author":"TM Hillhouse","year":"2014","unstructured":"Hillhouse TM, Porter JH (2014) Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule. Behav Pharmacol 25:80\u201391. doi: 10.1097\/FBP.0000000000000014","journal-title":"Behav Pharmacol"},{"key":"3451_CR29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/00000539-200212000-00025","volume":"95","author":"K Hirota","year":"2002","unstructured":"Hirota K, Hashimoto Y, Lambert DG (2002) Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in Chinese hamster ovary cells. Anesth Analg 95:1607\u20131610","journal-title":"Anesth Analg"},{"key":"3451_CR30","unstructured":"Institute of Laboratory Animal Resources (2011) Guide for the care and use of laboratory animals. 8th ed. Institute of Laboratory Animals Resources, Commission of Life Sciences, National Research Council, Washington DC"},{"key":"3451_CR31","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1017\/S1461145713000709","volume":"16","author":"V Katsidoni","year":"2013","unstructured":"Katsidoni V, Kastellakis A, Panagis G (2013) Biphasic effects of \u03949-tetrahydrocannabinol on brain stimulation reward and motor activity. Int J Neuropsychopharmacol 16:2273\u20132284","journal-title":"Int J Neuropsychopharmacol"},{"key":"3451_CR32","first-page":"1","volume":"60","author":"RT Kelleher","year":"1968","unstructured":"Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1\u201356","journal-title":"Ergeb Physiol"},{"key":"3451_CR33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.103.052027","volume":"306","author":"PJ Kenny","year":"2003","unstructured":"Kenny PJ, Gasparini F, Markou A (2003) Group II metabotropic and \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)\/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306:1068\u20131076","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2010.05.014","volume":"96","author":"BA Killinger","year":"2010","unstructured":"Killinger BA, Peet MM, Baker LE (2010) Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague\u2013Dawley rats. Pharmacol Biochem Behav 96:260\u2013265","journal-title":"Pharmacol Biochem Behav"},{"key":"3451_CR35","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-3565(25)24082-4","volume":"245","author":"W Koek","year":"1988","unstructured":"Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969\u2013974","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","volume":"224","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S (2011) Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res 224:107\u2013111","journal-title":"Behav Brain Res"},{"key":"3451_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1979.01780030055004","volume":"36","author":"C Kornetsky","year":"1979","unstructured":"Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979) Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 36:289\u2013292","journal-title":"Arch Gen Psychiatry"},{"key":"3451_CR38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.112.197780","volume":"343","author":"AJ Kwilasz","year":"2012","unstructured":"Kwilasz AJ, Negus SS (2012) Dissociable effects of the cannabinoid receptor agonists \u03949-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats. J Pharmacol Exp Ther 343:389\u2013400. doi: 10.1124\/jpet.112.197780","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0024-3205(96)00237-8","volume":"58","author":"M Lepore","year":"1996","unstructured":"Lepore M, Liu X, Savage V, Matalon D, Gardner EL (1996) Genetic differences in \u03949-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58:365\u2013372","journal-title":"Life Sci"},{"key":"3451_CR40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0091-3057(87)90587-9","volume":"27","author":"KL Marquis","year":"1987","unstructured":"Marquis KL, Moreton JE (1987) Animal models of intravenous phencyclinoid self-administration. Pharmacol Biochem Behav 27:385\u2013389","journal-title":"Pharmacol Biochem Behav"},{"key":"3451_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095816","volume":"13","author":"J McCambridge","year":"2007","unstructured":"McCambridge J, Winstock A, Hunt N, Mitcheson L (2007) 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Eur Addict Res 13:57\u201364","journal-title":"Eur Addict Res"},{"key":"3451_CR42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00008877-199204000-00007","volume":"3","author":"DE McMillan","year":"1992","unstructured":"McMillan DE, Wright DW, Wenger GR (1992) Effects of phencyclidine-like drugs on responding under multiple fixed ratio, fixed interval schedules. Behav Pharmacol 3:143\u2013147","journal-title":"Behav Pharmacol"},{"key":"3451_CR43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3565(25)31050-5","volume":"203","author":"JE Moreton","year":"1977","unstructured":"Moreton JE, Meisch RA, Stark L, Thompson T (1977) Ketamine self-administration by the rhesus monkey. J Pharmacol Exp Ther 203:303\u2013309","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2012","unstructured":"Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan Het Rot M et al (2012) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74:250\u2013256. doi: 10.1016\/j.biopsych.2012.06.022","journal-title":"Biol Psychiatry"},{"key":"3451_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-009-1770-6","volume":"210","author":"SS Negus","year":"2010","unstructured":"Negus SS, Morrissey E, Rosenberg M, Cheng K, Rice K (2010) Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) 210:149\u2013159","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/jpet.111.186783","volume":"340","author":"SS Negus","year":"2012","unstructured":"Negus SS, O\u2019Connell R, Morrissey E, Cheng K, Rice KC (2012a) Effects of peripherally restricted \u03ba opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J Pharmacol Exp Ther 340:501\u2013509. doi: 10.1124\/jpet.111.186783","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpain.2011.12.003","volume":"13","author":"SS Negus","year":"2012","unstructured":"Negus SS, Rosenberg MB, Altarifi AA, O\u2019Connell RH, Folk JE, Rice KC (2012b) Effects of the delta opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats. J Pain 13:317\u2013327. doi: 10.1016\/j.jpain.2011.12.003","journal-title":"J Pain"},{"key":"3451_CR48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000542-199803000-00029","volume":"88","author":"M Nishimura","year":"1998","unstructured":"Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S, Tohyama M (1998) Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 88:768\u2013774","journal-title":"Anesthesiology"},{"key":"3451_CR49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(96)00217-8","volume":"306","author":"ME Olds","year":"1996","unstructured":"Olds ME (1996) Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801. Eur J Pharmacol 306:23\u201332","journal-title":"Eur J Pharmacol"},{"key":"3451_CR50","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF00439557","volume":"97","author":"D Overton","year":"1989","unstructured":"Overton D, Shen CF, Ke G, Gazdick L (1989) Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus other) discrimination training. Psychopharmacology (Berl) 97:514\u2013520","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321803","volume":"63","author":"T P\u00e1len\u00ed\u010dek","year":"2011","unstructured":"P\u00e1len\u00ed\u010dek T, Fuj\u00e1kov\u00e1 M, Brunovsk\u00fd M, Bal\u00edkov\u00e1 M, Hor\u00e1\u010dek J, Gorman I et al (2011) Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology 63:202\u2013218","journal-title":"Neuropsychobiology"},{"key":"3451_CR52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pain.2009.04.010","volume":"144","author":"G Pereira Do Carmo","year":"2009","unstructured":"Pereira Do Carmo G, Stevenson GW, Carlezon WA, Negus SS (2009) Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144:170\u2013177","journal-title":"Pain"},{"key":"3451_CR53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2011.02.024","volume":"221","author":"GZ R\u00e9us","year":"2011","unstructured":"R\u00e9us GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J (2011) Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res 221:166\u2013171","journal-title":"Behav Brain Res"},{"key":"3451_CR54","first-page":"160","volume":"7","author":"BA Rocha","year":"1996","unstructured":"Rocha BA, Ward AS, Egilmez Y, Lytle DA, Emmett-Oglesby MW (1996) Tolerance to the discriminative stimulus and reinforcing effects of ketamine. Behav Pharmacol 7:160\u2013168","journal-title":"Behav Pharmacol"},{"key":"3451_CR55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpain.2012.11.006","volume":"14","author":"MB Rosenberg","year":"2013","unstructured":"Rosenberg MB, Carroll FI, Negus SS (2013) Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J Pain 14:246\u2013259. doi: 10.1016\/j.jpain.2012.11.006","journal-title":"J Pain"},{"key":"3451_CR56","first-page":"593","volume":"3","author":"DJ Sanger","year":"1992","unstructured":"Sanger DJ (1992) NMDA antagonists disrupt timing behaviour in rats. Behav Pharmacol 3:593\u2013600","journal-title":"Behav Pharmacol"},{"key":"3451_CR57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(76)90178-7","volume":"4","author":"DJ Sanger","year":"1976","unstructured":"Sanger DJ, Blackman DE (1976) Rate-dependent effects of drugs: a review of the literature. Pharmacol Biochem Behav 4:73\u201383","journal-title":"Pharmacol Biochem Behav"},{"key":"3451_CR58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.mp.4001682","volume":"10","author":"P Seeman","year":"2005","unstructured":"Seeman P, Ko F, Tallerico T (2005) Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10:877\u2013883","journal-title":"Mol Psychiatry"},{"key":"3451_CR59","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1100\/tsw.2007.315","volume":"7","author":"DTL Shek","year":"2007","unstructured":"Shek DTL (2007) Tackling adolescent substance abuse in Hong Kong: where we should and should not go. Sci World J 7:2021\u20132030","journal-title":"Sci World J"},{"key":"3451_CR60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0028-3908(87)90084-0","volume":"26","author":"DJ Smith","year":"1987","unstructured":"Smith DJ, Bouchal RL, DeSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, Crisp T (1987) Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 26:1253\u20131260","journal-title":"Neuropharmacology"},{"key":"3451_CR61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02246455","volume":"126","author":"DN Stephens","year":"1996","unstructured":"Stephens DN, Cole BJ (1996) AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology (Berl) 126:249\u2013259","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR62","unstructured":"Substance Abuse and Mental Health Services Administration (2013) Results from the 2012 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-46, HHS Publication No. (SMA) 13\u20134795. Rockville, MD: Substance Abuse and Mental Health Services Administration"},{"key":"3451_CR63","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/S0024-3205(02)01509-6","volume":"70","author":"JM Sundstrom","year":"2002","unstructured":"Sundstrom JM, Hall FS, Stellar JR, Waugh EJ (2002) Effects of isolation-rearing on intracranial self-stimulation reward of the lateral hypothalamus: baseline assessment and drug challenges. Life Sci 70:2799\u20132810","journal-title":"Life Sci"},{"key":"3451_CR64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0024-3205(00)00639-1","volume":"67","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Kato H, Aoki T, Tsuda M, Narita M, Misawa M (2000) Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci 67:383\u2013389","journal-title":"Life Sci"},{"key":"3451_CR65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-934-5_1","volume-title":"Animal models of drug addiction","author":"S Vlachou","year":"2011","unstructured":"Vlachou S, Markou A (2011) Intracranial self-stimulation. In: Olmstead MC (ed) Animal models of drug addiction. Humana, Totowa, pp 3\u201356"},{"key":"3451_CR66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2011.08.012","volume":"503","author":"N Wegener","year":"2011","unstructured":"Wegener N, Nagel J, Gross R, Chambon C, Greco S, Pietraszek M, Gravius A, Danysz W (2011) Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour. Neurosci Lett 503:68\u201372","journal-title":"Neurosci Lett"},{"key":"3451_CR67","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1464-410X.2012.11028.x","volume":"110","author":"AR Winstock","year":"2012","unstructured":"Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110:1762\u20131766","journal-title":"BJU Int"},{"key":"3451_CR68","doi-asserted-by":"crossref","unstructured":"Wise RA (1996) Addictive drugs and brain stimulation reward. Annual Review of Neuroscience 19:319\u2013340","DOI":"10.1146\/annurev.ne.19.030196.001535"},{"key":"3451_CR69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1749-6632.1992.tb25967.x","volume":"654","author":"RA Wise","year":"1992","unstructured":"Wise RA, Bauco P, Carlezon WA, Trojniar W (1992) Self-stimulation and drug reward mechanisms. Ann N Y Acad Sci 654:192\u2013198","journal-title":"Ann N Y Acad Sci"},{"key":"3451_CR70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002130000616","volume":"154","author":"WL Woolverton","year":"2001","unstructured":"Woolverton WL, Hecht GS, Agoston GE, Katz JL, Hauck Newman A (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology (Berl) 154:375\u2013382","journal-title":"Psychopharmacology (Berl)"},{"key":"3451_CR71","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0022-3565(25)32735-7","volume":"218","author":"AM Young","year":"1981","unstructured":"Young AM, Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218:720\u2013727","journal-title":"J Pharmacol Exp Ther"},{"key":"3451_CR72","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"3451_CR73","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2012","unstructured":"Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al (2012) Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71:939\u2013946","journal-title":"Biol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3451-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3451-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3451-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:56:05Z","timestamp":1746132965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3451-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":73,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3451"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3451-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}